how much weight can you lose on a glp 1 Rx Trends: Real-World Data GLP-1s for Loss Two Years After Stopping GLP-1s,

10.1006/bbrc.2000.3763 75 LiD.-j.YueQ.LiuL.CheK.-k.LiuX.-m.HuC.-h

The list of FDA-approved indications for this class of medication has grown as of late (and currently includes type 2 diabetes, obesity, cardiovascular event risk reduction, obstructive sleep apnea, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease), and areas of interest for potential future indications are just as long and farreaching

Sodium-Glucose Cotransport Protein 2 Inhibitors in Patients With Type 2 Diabetes and Acute Kidney Disease

This approach enables a broad exploration of mechanisms and clinical implications, but it also introduces the potential for selection bias